Anne Wojcicki

Anne Wojcicki. She is an American business executive and biotechnology entrepreneur, best known as the co-founder and chief executive officer of the personal genomics and biotechnology company 23andMe. A prominent figure in the direct-to-consumer genetic testing industry, Wojcicki has been a leading advocate for empowering individuals with access to their own genetic information and for advancing genetic research on a massive scale. Her work has positioned her at the intersection of healthcare, technology, and consumer empowerment, significantly influencing modern approaches to personalized medicine.

Early life and education

Anne Wojcicki was born in San Mateo County, California, into a family with strong academic roots; her mother, Esther Wojcicki, is a noted journalism educator, and her father, Stanley Wojcicki, was a professor of physics at Stanford University. She grew up on the campus of Stanford University, immersed in an environment that valued science and education. Wojcicki attended Yale University, where she initially studied biology before switching her major, ultimately graduating in 1996 with a Bachelor of Science in biology. Her early career included work as a healthcare analyst on Wall Street, focusing on biotechnology companies, which provided her with critical insights into the business and science of healthcare innovation.

Career

Before founding her own company, Anne Wojcicki worked as a healthcare analyst for several years at Investor AB and later at Passport Capital, where she analyzed biotechnology and pharmaceutical firms. This experience in finance and investment banking gave her a deep understanding of the capital and strategic challenges facing life sciences companies. Her entrepreneurial journey began in earnest when she co-founded 23andMe in 2006, aiming to democratize access to genetic information. Beyond this venture, she has been an active angel investor and advisor in the technology and biotech sectors, supporting numerous startups. Wojcicki has also served on the board of directors for the X Prize Foundation and has been involved with various initiatives at the Broad Institute.

23andMe

Anne Wojcicki co-founded 23andMe in April 2006 alongside Linda Avey and Paul Cusenza, with early backing from major investors like Google and Genentech. The company's name references the 23 pairs of chromosomes in a human cell. Its flagship product is a direct-to-consumer DNA testing kit that provides customers with reports on genetic ancestry, carrier status for certain heritable conditions, and genetic health risks. Under Wojcicki's leadership as CEO, the company navigated a significant regulatory challenge with the U.S. Food and Drug Administration (FDA), which in 2013 ordered the company to halt marketing its health-related genetic reports. After submitting extensive data, 23andMe later gained FDA authorization for several health-related reports. A major milestone was the company's transition to a publicly-traded entity via a special-purpose acquisition company (SPAC) merger with VG Acquisition Corp. in 2021, listed on the Nasdaq under the ticker symbol ME. Wojcicki has emphasized building a large research database by aggregating customer genetic data, leading to numerous collaborations with institutions like the National Institutes of Health and Pfizer for genetic research into conditions such as Parkinson's disease and lupus.

Personal life

Anne Wojcicki was married to Google co-founder Sergey Brin from 2007 until their separation in 2013 and subsequent divorce in 2015; they have two children together. Following her divorce, she was in a long-term relationship with former Major League Baseball star Alex Rodriguez; the couple announced their engagement in March 2023. She is the sister of Susan Wojcicki, the former CEO of YouTube, and Janet Wojcicki, an anthropology professor at the University of California, San Francisco. Wojcicki is known for her advocacy in health and wellness, often speaking about nutrition, exercise, and preventive healthcare. She resides primarily in Los Angeles, California.

Recognition and awards

Anne Wojcicki has received widespread recognition for her impact on biotechnology and business. She has been named to the Time 100, Time magazine's list of the world's most influential people, and has been featured on the Forbes list of America's Self-Made Women. Other notable honors include being included in the Forbes "World's 100 Most Powerful Women" list and receiving the Biotechnology Innovation Organization (BIO) Biotech Humanitarian Award. Her company, 23andMe, has also won awards, including a National Design Award from the Smithsonian Institution's Cooper Hewitt, Smithsonian Design Museum.